NCT02694562View on ClinicalTrials.gov

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Colorectal Carcinoma
Interventions
DEVICE

40um Embozene TANDEM Microspheres

40um Embozene TANDEM Microspheres loaded with Irinotecan (up to 150 mg).

Trial Locations (1)

20141

European Institute of Oncology, Milan

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY